GLAXOSMITHKLINE PHARMACEUTICALS
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Income Statement History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹3,568 Cr | ₹3,594 Cr | ₹3,125 Cr | ₹3,362 Cr | ₹3,128 Cr |
Sales | ₹3,543 Cr | ₹3,580 Cr | ₹3,095 Cr | ₹3,325 Cr | ₹3,089 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | ₹24 Cr | ₹13 Cr | ₹20 Cr | ₹24 Cr | ₹25 Cr |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹1.11 Cr | ₹1.24 Cr | ₹9.43 Cr | ₹13 Cr | ₹13 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹3,252 Cr | ₹3,278 Cr | ₹2,926 Cr | ₹3,224 Cr | ₹3,128 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹69 Cr | ₹16 Cr | ₹-38 Cr | ₹-35 Cr | ₹26 Cr |
Raw Material Consumed | ₹1,216 Cr | ₹1,341 Cr | ₹1,295 Cr | ₹1,343 Cr | ₹1,332 Cr |
Opening Raw Materials | ₹107 Cr | ₹91 Cr | ₹76 Cr | ₹116 Cr | ₹103 Cr |
Purchases Raw Materials | ₹425 Cr | ₹627 Cr | ₹487 Cr | ₹435 Cr | ₹699 Cr |
Closing Raw Materials | ₹104 Cr | ₹107 Cr | ₹91 Cr | ₹76 Cr | ₹116 Cr |
Other Direct Purchases / Brought in cost | ₹788 Cr | ₹729 Cr | ₹823 Cr | ₹869 Cr | ₹646 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹30 Cr | ₹28 Cr | ₹26 Cr | ₹33 Cr | ₹28 Cr |
Electricity & Power | ₹30 Cr | ₹28 Cr | ₹26 Cr | ₹33 Cr | ₹28 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹595 Cr | ₹610 Cr | ₹616 Cr | ₹629 Cr | ₹537 Cr |
Salaries, Wages & Bonus | ₹542 Cr | ₹553 Cr | ₹564 Cr | ₹571 Cr | ₹478 Cr |
Contributions to EPF & Pension Funds | ₹22 Cr | ₹23 Cr | ₹25 Cr | ₹26 Cr | ₹24 Cr |
Workmen and Staff Welfare Expenses | ₹21 Cr | ₹19 Cr | ₹19 Cr | ₹19 Cr | ₹22 Cr |
Other Employees Cost | ₹11 Cr | ₹15 Cr | ₹8.94 Cr | ₹13 Cr | ₹12 Cr |
Other Manufacturing Expenses | ₹99 Cr | ₹120 Cr | ₹111 Cr | ₹108 Cr | ₹116 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | - | - | - | - | - |
Repairs and Maintenance | ₹19 Cr | ₹22 Cr | ₹26 Cr | ₹17 Cr | ₹21 Cr |
Packing Material Consumed | - | - | - | - | - |
Other Mfg Exp | ₹80 Cr | ₹98 Cr | ₹85 Cr | ₹91 Cr | ₹95 Cr |
General and Administration Expenses | ₹189 Cr | ₹144 Cr | ₹117 Cr | ₹165 Cr | ₹179 Cr |
Rent , Rates & Taxes | ₹66 Cr | ₹29 Cr | ₹40 Cr | ₹37 Cr | ₹42 Cr |
Insurance | ₹5.10 Cr | ₹5.35 Cr | ₹5.44 Cr | ₹4.04 Cr | ₹4.38 Cr |
Printing and stationery | ₹12 Cr | ₹12 Cr | ₹9.28 Cr | ₹11 Cr | ₹9.73 Cr |
Professional and legal fees | ₹23 Cr | ₹36 Cr | ₹12 Cr | ₹12 Cr | ₹22 Cr |
Traveling and conveyance | ₹76 Cr | ₹55 Cr | ₹47 Cr | ₹88 Cr | ₹74 Cr |
Other Administration | ₹84 Cr | ₹62 Cr | ₹51 Cr | ₹101 Cr | ₹100 Cr |
Selling and Distribution Expenses | ₹181 Cr | ₹200 Cr | ₹125 Cr | ₹212 Cr | ₹203 Cr |
Advertisement & Sales Promotion | ₹109 Cr | ₹128 Cr | ₹67 Cr | ₹138 Cr | ₹120 Cr |
Sales Commissions & Incentives | ₹19 Cr | ₹21 Cr | ₹20 Cr | ₹20 Cr | ₹19 Cr |
Freight and Forwarding | ₹52 Cr | ₹51 Cr | ₹37 Cr | ₹54 Cr | ₹63 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | - | - | - | - | - |
Miscellaneous Expenses | ₹69 Cr | ₹58 Cr | ₹76 Cr | ₹113 Cr | ₹107 Cr |
Bad debts /advances written off | - | - | - | - | - |
Provision for doubtful debts | - | - | - | - | - |
Losson disposal of fixed assets(net) | - | - | ₹0.06 Cr | - | - |
Losson foreign exchange fluctuations | ₹9.91 Cr | ₹5.14 Cr | - | ₹12 Cr | ₹4.37 Cr |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹59 Cr | ₹53 Cr | ₹76 Cr | ₹100 Cr | ₹103 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹2,447 Cr | ₹2,516 Cr | ₹2,327 Cr | ₹2,567 Cr | ₹2,527 Cr |
Operating Profit (Excl OI) | ₹804 Cr | ₹762 Cr | ₹598 Cr | ₹657 Cr | ₹601 Cr |
Other Income | ₹101 Cr | ₹76 Cr | ₹111 Cr | ₹79 Cr | ₹102 Cr |
Interest Received | ₹70 Cr | ₹71 Cr | ₹111 Cr | ₹76 Cr | ₹77 Cr |
Dividend Received | - | - | - | - | - |
Profit on sale of Fixed Assets | ₹0.03 Cr | ₹0.32 Cr | - | ₹2.33 Cr | ₹1.41 Cr |
Profits on sale of Investments | ₹31 Cr | ₹0.59 Cr | - | - | - |
Provision Written Back | - | ₹0.01 Cr | - | ₹0.47 Cr | ₹23 Cr |
Foreign Exchange Gains | - | - | - | - | - |
Others | ₹0.04 Cr | ₹3.70 Cr | ₹0.01 Cr | - | ₹0.48 Cr |
Operating Profit | ₹905 Cr | ₹838 Cr | ₹709 Cr | ₹736 Cr | ₹703 Cr |
Interest | ₹1.81 Cr | ₹2.00 Cr | ₹3.53 Cr | ₹6.34 Cr | ₹0.55 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | - | - | - | - | - |
Intereston Fixed deposits | ₹0.41 Cr | ₹0.26 Cr | ₹0.35 Cr | ₹0.22 Cr | ₹0.22 Cr |
Bank Charges etc | - | - | - | - | - |
Other Interest | ₹1.40 Cr | ₹1.74 Cr | ₹3.18 Cr | ₹6.12 Cr | ₹0.33 Cr |
PBDT | ₹903 Cr | ₹836 Cr | ₹705 Cr | ₹730 Cr | ₹703 Cr |
Depreciation | ₹66 Cr | ₹68 Cr | ₹79 Cr | ₹83 Cr | ₹49 Cr |
Profit Before Taxation & Exceptional Items | ₹837 Cr | ₹767 Cr | ₹627 Cr | ₹647 Cr | ₹654 Cr |
Exceptional Income / Expenses | ₹-0.97 Cr | ₹12 Cr | ₹-173 Cr | ₹-341 Cr | ₹29 Cr |
Profit Before Tax | ₹836 Cr | ₹779 Cr | ₹454 Cr | ₹306 Cr | ₹683 Cr |
Provision for Tax | ₹229 Cr | ₹398 Cr | ₹167 Cr | ₹213 Cr | ₹237 Cr |
Current Income Tax | ₹247 Cr | ₹220 Cr | ₹159 Cr | ₹235 Cr | ₹193 Cr |
Deferred Tax | ₹-18 Cr | ₹-9.40 Cr | ₹8.05 Cr | ₹-48 Cr | ₹44 Cr |
Other taxes | - | ₹188 Cr | - | ₹25 Cr | - |
Profit After Tax | ₹608 Cr | ₹381 Cr | ₹287 Cr | ₹93 Cr | ₹445 Cr |
Extra items | ₹3.05 Cr | ₹1,314 Cr | ₹71 Cr | - | - |
Minority Interest | - | - | - | - | - |
Share of Associate | - | - | - | - | - |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹611 Cr | ₹1,695 Cr | ₹358 Cr | ₹93 Cr | ₹445 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹1,743 Cr | ₹556 Cr | ₹876 Cr | ₹1,191 Cr | ₹1,103 Cr |
Appropriations | ₹2,353 Cr | ₹2,251 Cr | ₹1,234 Cr | ₹1,284 Cr | ₹1,548 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | - |
Other Appropriation | ₹1,525 Cr | ₹508 Cr | ₹678 Cr | ₹408 Cr | ₹357 Cr |
Equity Dividend % | ₹320.00 | ₹900.00 | ₹300.00 | ₹400.00 | ₹200.00 |
Earnings Per Share | ₹36.05 | ₹100.04 | ₹21.14 | ₹5.50 | ₹26.29 |
Adjusted EPS | ₹36.05 | ₹100.04 | ₹21.14 | ₹5.50 | ₹26.29 |
Compare Income Statement of peers of GLAXOSMITHKLINE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAXOSMITHKLINE PHARMACEUTICALS | ₹31,658.3 Cr | -1.5% | -11.3% | 51% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹365,311.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹108,623.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,134.3 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹97,408.4 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹92,794.9 Cr | 5% | 10.4% | 109.1% | Stock Analytics |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAXOSMITHKLINE PHARMACEUTICALS | -1.5% |
-11.3% |
51% |
SENSEX | -2.6% |
-0% |
21% |
You may also like the below Video Courses